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Abstract To study the role of the Cav2.1/K1A (P/Q-type) Ca2+
channel in somatosensory pain processing, behavioral and
electrophysiological studies were conducted using the leaner
(tgla/tgla) mouse. Behavioral analyses in tgla/tgla revealed reduced
responses to mechanical stimuli, and enhanced responses to heat
stimuli. Electrophysiological analyses showed that tgla/tgla had a
significantly reduced ability to evoke dorsal root potentials,
suggesting a functional deficit in the spinal dorsal horn local
circuitry responsible for presynaptic inhibition of primary
sensory fibers. These results suggest the critical importance of
the P/Q-type channel in modulation of acute somatosensory pain
transmission in spinal cord. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Calcium entry through voltage-dependent Ca2 channels
(VDCCs) contributes directly to the elevation of intracellular
Ca2 concentration, and regulates many aspects of neural
activities from short-term responses including neurotransmit-
ter release, to sustained changes such as gene expression and
cell di¡erentiation [1]. VDCCs are generally classi¢ed into two
groups, high-voltage-activated (HVA) and low-voltage-acti-
vated (LVA) channels [2]. HVA channel includes L, N, P/Q
and R subtypes, which are distinguished by their voltage de-
pendence, kinetics and pharmacology. Ca2 currents through
LVA channels are known as T-type currents.
The P/Q-type channel is suggested to participate critically in
neural excitability, integration, and Ca2-dependent neuro-
transmitter release, based on their characteristic localization
on somatodendritic membranes and presynaptic terminals of
most central and peripheral neurons [2]. The discovery of P/Q-
type channel mutations in mice and humans with inherited
neurological diseases [3] further substantiates a pivotal role
of P/Q-type channels in neural network functions.
Important roles of Ca2 in£ux through VDCCs have also
been proposed for pain signaling [4]. For example, P/Q-type
as well as N-type channels are well known to be involved in
the release of nociceptive neurotransmitters, such as gluta-
mate, calcitonin gene-related peptide and substance P, from
primary sensory neurons [5^7]. Furthermore, analgesia by
narcotic drugs is believed to be mediated partly by the inhi-
bition of P/Q- and N-type channels through the opioid recep-
tor^G-protein systems, thereby decreasing nociceptive neuro-
transmitter release [8,9]. For these reasons, the modulation of
P/Q- and N-type channel functions, directly by channel block-
ers or indirectly through receptor^G-protein pathways, has
been explored extensively as a therapeutic means of control-
ling pain symptoms [4,10]. However, the importance of each
Ca2 in£ux through VDCC subtypes in physiological and
pathological pain states remains to be characterized.
To understand the physiological role of the P/Q-type chan-
nel in somatosensory pain processing, we utilized the leaner
(tgla/tgla) mutant mouse. This mouse has a mutation at the
splice donor consensus sequence on the gene encoding the
VDCC K1A (Cav2.1) subunit [11,12], the pore-forming subunit
of P/Q-type channels [2,13,14], which results in skipping the
exon/intron or in failure to splice out the succeeding intron. In
both cases, the tgla mutation causes truncation of mRNA and
expression of P/Q-type channels containing aberrant carboxy-
terminal sequences. The mutation results in a dramatic reduc-
tion of Ca2 current in cerebellar Purkinje cells [15^17], where
the P-type contributes V90% of the whole cell Ca2 current.
This seems to be partly caused by the reduction of open prob-
ability by the mutation [15]. Reduction of channel expression
has also been reported [12], although there is another report
showing no change of the channel expression [18]. Recently,
the production of P/Q-type channel knockout mice has been
reported by two groups [13,14]. The phenotypes of these mice
were very similar to that of tgla/tgla, suggesting that the tgla/
tgla phenotype is caused by the strong reduction of P/Q-type
current. Therefore, we considered that the tgla/tgla mouse was
useful in exploring the physiological role of P/Q-type channels
in pain transmission.
2. Materials and methods
All experimental protocols involving pain behavioral studies were
reviewed and approved by the Animal Care Committee of Tokyo
Medical and Dental University.
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 0 5 2 - 6
*Corresponding author. Fax: (81)-3-5803 0122.
E-mail address: t-tanabe.mphm@tmd.ac.jp (T. Tanabe).
Abbreviations: ACSF, arti¢cial cerebrospinal £uid; CAP, compound
action potential; CV, conduction velocity; DRP, dorsal root poten-
tial ; HVA, high-voltage-activated; LVA, low-voltage-activated;
MSR, monosynaptic re£ex; sVRP, slow ventral root potential;
VDCC, voltage-dependent Ca2 channel
FEBS 25443 12-11-01
FEBS 25443 FEBS Letters 508 (2001) 181^186
2.1. Animals
Breeding pairs of heterozygous leaner (tgla/+) on the C57BL/6J
background were originally obtained from The Jackson Laboratory
(Bar Harbor, ME, USA). Oligosyndactylism (Os) is a skeletal muta-
tion tightly linked to the tgla mutation. Heterozygous Os/+ mice,
identi¢ed by the oligosyndactylism, were inferred to be heterozygous
for the tgla mutation. Mice with no oligosyndactylism were inferred to
be homozygous for the tgla mutation. Because homozygous Os/Os is
embryonic lethal and the tgla/+ strain we used has been backcrossed
for 14 generations with the C57BL/6J strain (indicating more than
99.9% inbred), we used age-matched pups from C57BL/6J wild-type
mating as wild-type (+/+) controls (Japan Clea, Shizuoka, Japan).
tgla/tgla mice become ataxic beginning after postnatal day 10 (P10).
Therefore, we conducted pain behavioral experiments between P7 and
P9. Electrophysiological studies, except compound action potential
(CAP) experiments, were conducted with younger animals (P1^P6)
in order to obtain the higher integrity of electrical responses of the
isolated preparations described below.
2.2. In vitro electrophysiological experiments
Isolated spinal cord preparations and isolated spinal cord^periph-
eral nerve preparations of neonatal mice were prepared as described
previously [19]. The preparations were perfused (2.5 ml/min) with
arti¢cial cerebrospinal £uid (ACSF) saturated with a gas mixture of
95% O2 : 5% CO2 at room temperature (25^27‡C). The composition of
ACSF was as follows (mM): NaCl 138.6; KCl 3.35; NaHCO3 20.9;
glucose 10.0; CaCl2 1.25; MgCl2 1.15 (pH 7.4 after gas saturation). A
tight-¢tting suction electrode was used for extracellular recording
from a ventral root (L3^L5) or a dorsal root (L4). Another suction
electrode was used for electrical stimulation of the dorsal root of the
same segment or peripheral (femoral) nerve. A single shock with a
square pulse of 500 Ws in duration and 15^20 V in amplitude, supra-
maximal for monosynaptic re£ex (MSR) and slow ventral root poten-
tial (sVRP), was applied. Changes in potential in the ventral or dorsal
root were monitored via a DC ampli¢er with inputs to a pen recorder
and a personal computer running Axotape version 2 (Axon Instru-
ments, Foster City, CA, USA). The spinal re£exes of fast time courses
were stored in a transient memory device in AC mode and then
recorded with the pen recorder using an expanded time scale.
For the CAP experiment, L5 dorsal root connecting to the sciatic
nerve was isolated from P7^9 mice. Electrical stimulation (various
intensities) was applied to the sciatic nerve and CAP was recorded
from L5 dorsal root in the same manner as described above. Primary
a¡erents could be divided into three distinct groups corresponding to
AK/L-, AN-, and C-¢bers, on the basis of the activation thresholds and
conduction velocities (CVs) of CAPs. At a pulse width of 10 Ws and
stimulus intensity of 6 10 V, only an AK/L wave was detectable with
maximum amplitude at 10^12 V (data not shown). When the pulse
width was gradually increased (stimulus intensity was ¢xed at 12 V),
several additional responses were elicited. A C-¢ber volley, which was
identi¢ed by its capsaicin sensitivity (1 WM), was evoked at around
150^250 Ws. Thus, activation thresholds of AK/L- and C-¢bers were
reported as voltage (V) and pulse width (Ws) units. Although several
intermediate components between AK/L- and C-¢ber volleys were ob-
served, these components were relatively small and variable, and
therefore we did not analyze these components.
2.3. Behavioral analyses
All behavioral experiments were performed in a sound-proof room
during the light cycle. Mechanical sensitivity was measured as the
frequency of foot withdrawals out of 20 trials elicited by a de¢ned
mechanical stimulus with calibrated Von Frey hairs (Stoelting, Wood
Dale, IL, USA). Hindpaw thermal sensitivity was evaluated with a
plantar test apparatus (Ugo Basile, Comerio, Italy). The heat stimulus
shut o¡ automatically when the hindpaw moved, providing hindpaw
withdrawal latencies accurate to within 0.1 s. Four trials, at least
5 min apart, were conducted on each hindpaw, alternating between
right and left hindpaws. Thermal sensitivity of the tail was evaluated
by the method of Blass et al. [20]. The pup was placed on a piece of
cardboard so that its tail extended beyond the cardboard’s edge. The
tail was then lowered onto the 48‡C hotplate by setting the cardboard
support down next to the heated surface. Latency (s) either to lift the
tail or to curl it away from the heated surface was recorded.
2.4. Pharmacology
Bicuculline methiodide, capsaicin and cytochrome c were purchased
from Sigma. g-Agatoxin-IVA (g-Aga-IVA), g-conotoxin-GVIA (g-
CTx-GVIA), dynorphin A(1^17), endomorphin-1 and endomorphin-2
were from Peptide Institute, Osaka, Japan. Tetrodotoxin (TTX) was
from Sankyo, Tokyo, Japan. GR82334 ([D-Pro9,[spiro-Q-lactam]-
Leu10,Trp11]physalaemin-(1^11)) was from Peninsula Laboratories,
Belmont, CA, USA. All drugs were made up as concentrated stock
solutions in MilliQ (18.3 M6) water (or dimethyl sulfoxide for cap-
saicin), aliquoted and stored at 320‡C. Aliquots were thawed and
diluted to desired concentrations in ACSF immediately prior to use
and applied to spinal cords by perfusion. The inhibitory e¡ects of
VDCC blockers, GR82334 and opioid peptides on the nerve-evoked
MSR and sVRP were evaluated by comparing the average of three
control responses with the average of three responses under the steady
e¡ects of these agents. In order to obtain steady depressant e¡ects, the
compounds were applied to the spinal cord for at least 10^15 min.
The inhibitory e¡ect of bicuculline on the dorsal root potential (DRP)
was also evaluated in the same manner. For MSR, the peak amplitude
was compared, whereas the magnitude of the integrated area
(mVWmin) of the depolarization was compared for sVRP. For DRP,
the peak amplitude and the magnitude of the integrated area (mVWs)
were measured. The VDCC blockers were applied in the presence of
0.1 mg/ml cytochrome c to saturate non-speci¢c binding sites. Cyto-
chrome c did not a¡ect the spinal re£exes (data not shown). In the
experiment examining the depolarizing e¡ect of capsaicin on ventral
root, capsaicin was applied to the spinal cord for 60 s at an interval of
40^50 min to minimize tachyphylaxis. The magnitude of the depola-
rizing response (estimated as the integrated area) was normalized by
the magnitude of the depolarization evoked by a 10 mM KCl solution
applied for 20 s in the presence of TTX (0.3 WM).
2.5. Statistical analysis
Experimental data are expressed as mean þ S.E.M. We used the
Mann^Whitney test to compare data from +/+ and tgla/tgla mice
and evaluate the e¡ects of drugs on spinal re£exes. For a multiple
comparison, we used Tukey’s test. P6 0.05 was considered statistical-
ly signi¢cant.
3. Results
3.1. E¡ects of VDCC blockers on the spinal re£exes of
leaner mice in vitro
We ¢rst examined the e¡ect of VDCC blockers on the dor-
sal root-evoked responses of ventral roots in the isolated spi-
nal cord preparation in +/+ and tgla/tgla mice (Fig. 1). Elec-
trical stimulation of a dorsal root at C-¢ber strength evoked
MSR followed by a prolonged depolarization lasting for
about 30 s (sVRP) on the ipsilateral ventral root of the
same segment. The average value of amplitude of MSR and
integrated area of sVRP recorded from tgla/tgla (5.07 þ 0.27
mV and 0.216 þ 0.014 mVWmin, respectively, n = 32) were
slightly smaller than those of +/+ (5.59 þ 0.18 mV and
0.269 þ 0.012 mVWmin, respectively, n = 54). The di¡erence of
sVRP magnitude reached a statistically signi¢cant level
(p6 0.05). The smaller sizes of MSR and sVRP may be due
to the absence of a P/Q channel component of MSR and
sVRP in tgla/tgla mice (see below). The reduced tachykininer-
gic component in the tgla/tgla sVRP may also have contributed
to the size reduction (see Section 3.4).
Bath application of the P/Q-type channel blocker g-Aga-
IVA (50 nM) to +/+ spinal cord produced a marked inhibi-
tion of sVRP (to 51.9 þ 6.83% of the control response,
P6 0.001, n = 6) with a slight inhibition of MSR (to
89.5 þ 3.68% of the control response, P6 0.05, n = 6) (Fig.
1A,C). In contrast, the same dosage of g-Aga-IVA had no
e¡ect on either the sVRP (98.0 þ 6.46% of control response,
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n = 4) or MSR (98.1 þ 0.74% of the control response, n = 4) of
tgla/tgla (Fig. 1B,D). Following the application of g-Aga-IVA,
further application of the N-type channel blocker g-CTx-
GVIA (100 nM) completely blocked the remaining compo-
nents of both MSR and sVRP. These results suggest that
the P/Q-type channel component in both MSR and sVRP is
absent in tgla/tgla spinal cord. Furthermore, together with the
¢nding that the sVRP magnitude in tgla/tgla is only slightly
smaller than that in +/+ mice, the experiments with toxins
strongly indicate that the N-type channel compensates most
of the P/Q-type channel component in tgla/tgla spinal cord.
3.2. Altered acute nociception of tgla/tgla mice
Acute mechanical sensitivity was estimated by applying Von
Frey ¢laments of three di¡erent bending forces (Fig. 2A). In
+/+ mice, there was an increase in the number of withdrawal
responses as the bending force increased. Compared with +/+,
the numbers of withdrawal responses in tgla/tgla were greatly
reduced. The tgla/+ mice also showed signi¢cantly smaller
numbers of responses with 27.5 and 166 mg Von Frey ¢la-
ments.
In contrast to the mechanical response, tgla/tgla mice
showed signi¢cantly enhanced thermal responses in paw £ick
(Fig. 2B) and tail £ick (Fig. 2C) tests compared to +/+ and
tgla/+ mice. The +/+ and tgla/+ mice showed similar thermal
sensitivities in both tests.
3.3. Compound action potentials
The phenotype revealed by the above pain-related behavio-
ral analyses suggests that tgla/tgla mice have some de¢cits in
spinal nociceptive pathways, since these three pain-related be-
haviors are known to be tightly associated with the spinal
re£ex responses [21]. Therefore, we further attempted to eval-
uate the spinal re£exes of tgla/tgla and +/+ mice by using the
isolated spinal cord preparations. Firstly, we tested whether
the activation thresholds and CVs for A- and C-primary af-
ferent ¢bers are normal in tgla/tgla mice. For this purpose, we
recorded CAPs of L5 dorsal root evoked by electrical stimu-
lation of the sciatic nerve, which innervates the plantar surface
of the hindpaw, the region where mechanical and thermal
stimuli were applied in the behavioral tests. The activation
threshold and CV corresponding to the AK/L-¢ber
(3.69 þ 0.20 V and 10.8 þ 1.34 m/s, respectively, n = 12) and
Fig. 1. E¡ects of VDCC blockers on the dorsal root-evoked spinal
re£exes of neonatal +/+ and tgla/tgla mice in vitro. A,B: E¡ects of a
P/Q-type VDCC blocker, g-Aga-IVA, and an N-type blocker, g-
CTx-GVIA, on MSR (upper traces) and sVRP (lower traces). The
upper traces show the record of the fast re£ex responses during 78-
ms post-stimulus periods. Initial sharp spikes represent the MSR.
The lower traces show continuous chart records of the DC poten-
tial. Records in A and B were taken from +/+ and tgla/tgla spinal
cord preparations, respectively. C,D: Time course of inhibition of
MSR and sVRP by g-Aga-IVA and g-CTx-GVIA in +/+ (C) and
tgla/tgla (D) mice (+/+: n = 6^9; tgla/tgla : n = 4^5). The ordinate scale
represents the amplitude of MSR or magnitude of sVRP, which was
expressed as percentage against averaged control responses.
Fig. 2. Acute nociceptive responses. A: Number of hindpaw with-
drawal responses out of 20 trials (ordinate scale) was plotted against
each force of Von Frey ¢laments (+/+: n = 15; tgla/+: n = 5; tgla/
tgla : n = 16). B: Paw £ick test. Hindpaw withdrawal latencies to
noxious thermal stimuli with two di¡erent heat intensities (infrared
intensity (IRIT) 10 and 30) were measured (+/+: n = 19, 36; tgla/+:
n = 8, 8; tgla/tgla : n = 20, 27). C: Tail £ick test (+/+: n = 23; tgla/+:
n = 6; tgla/tgla : n = 11). Signi¢cant di¡erences: *P6 0.05 and
**P6 0.005.
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C-¢ber (224 þ 32.8 Ws and 0.39 þ 0.02 m/s, respectively, n = 15)
from +/+ were not signi¢cantly di¡erent from those of tgla/tgla
(4.23 þ 0.49 V and 11.0 þ 2.18 m/s, respectively, for AK/L-¢ber,
n = 12; 165 þ 19.0 Ws and 0.36 þ 0.02 m/s, respectively, for C-
¢ber, n = 15). These results suggest that electrical activities of
primary sensory axons in tgla/tgla mice appear to be normal.
3.4. E¡ects of capsaicin and a tachykinin receptor antagonist
To explore the possible functional de¢cit of C-¢ber-medi-
ated responses in tgla/tgla spinal cord, we examined the e¡ects
of capsaicin and a tachykinin receptor antagonist.
Capsaicin is known to excite a subset of primary sensory
neurons (mainly small diameter nociceptive neurons), and
cause a release and a depletion of sensory neuropeptides in-
cluding tachykinins (substance P and neurokinin A) [22]. Bath
application of capsaicin (10^100 nM) for 60 s to the spinal
cord preparations from +/+ and tgla/tgla mice evoked nearly
identical concentration-dependent ventral root depolarization,
suggesting that the capsaicin-sensitive component in C-¢ber
response is not a¡ected in tgla/tgla (Fig. 3A).
Several lines of evidence obtained from newborn rat spinal
cord preparations suggest that the nerve-evoked sVRP repre-
sents a C-¢ber-evoked nociceptive response in which tachyki-
ninergic primary a¡erents are involved (for review, see [23]).
Similar to the newborn rat spinal cord [23,24], a tachykinin
NK1 receptor antagonist, GR82334, dose-dependently inhib-
ited the femoral nerve-evoked sVRP in +/+ spinal cord.
GR82334 also depressed the sVRP in tgla/tgla, but to a lesser
extent (Fig. 3B).
3.5. Possible functional de¢cits in endogenous antinociceptive
mechanisms in tgla/tgla spinal cord
The altered nociceptive behavior of tgla/tgla mice may result
from functional de¢cits of endogenous antinociceptive mech-
anisms. To test this possibility, we ¢rst compared the inhib-
itory e¡ects of several opioid peptides (W-receptor agonists,
endomorphin-1 and -2, and a U-receptor agonist, dynorphin
A(1^17)) on the dorsal root-evoked sVRP; however, the dose^
response curves for these peptides were essentially identical in
each case (Fig. 3C).
To further examine the mechanism of the altered nocicep-
Fig. 3. E¡ects of capsaicin, a tachykinin receptor antagonist and
opioid peptides. A: Concentration^depolarization curves for capsai-
cin. The ordinate scale represents the value of capsaicin-evoked re-
sponse normalized by the response of KCl-evoked depolarization in
the presence of TTX (0.3 WM) (+/+: n = 4; tgla/tgla : n = 6). B: E¡ect
of GR82334, a tachykinin receptor antagonist, on the sVRP evoked
by femoral nerve stimulation in the isolated spinal cord^peripheral
nerve preparation (+/+: n = 5; tgla/tgla : n = 5). C: E¡ects of opioid
peptides on the dorsal root-evoked sVRP. Concentration^inhibition
curves for W-opioid receptor agonists, endomorphin-1 (EM-1) and
endomorphin-2 (EM-2), and a U-opioid receptor agonist, dynorphin
A(1^17) (Dyn A) (+/+: n = 4; tgla/tgla : n = 4). In B and C, the ordi-
nate scale represents the magnitude of sVRP, which was expressed
as percentage against the average of three control responses.
Fig. 4. Comparison of DRPs between +/+ and tgla/tgla mice. A:
Stimulation^peak amplitude relationships. Stimulus intensities were
¢xed at 10^12 V (+/+: n = 8; tgla/tgla : n = 5). B: E¡ect of bicucul-
line, a GABAA receptor antagonist, on the peak amplitude of DRP
(+/+: n = 7; tgla/tgla : n = 4). DRPs were evoked by intense stimula-
tion of the femoral nerve with 800^1000 Ws pulse width and 10^12
V intensity. C: Stimulation^response relationships of sDRP. Stimu-
lus intensities were ¢xed at 10^12 V (+/+: n = 8; tgla/tgla : n = 5).
Representative sample records from +/+ and tgla/tgla are shown in
the upper panel. The magnitude of sDRP represented by the inte-
grated area (mVWs) was plotted against pulse width (lower panel).
*P6 0.05, signi¢cant di¡erence between +/+ and tgla/tgla.
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tive behavior of tgla/tgla mice, we attempted to evaluate the
function of another endogenous antinociceptive mechanism, Q-
aminobutyric acid (GABA)-mediated inhibition. For this pur-
pose, we recorded DRP and examined the stimulus^response
relationships. DRP is derived from depolarization of the ter-
minals of the primary a¡erent ¢bers (that is, primary a¡erent
depolarization: PAD) and PAD is believed to be partly re-
sponsible for GABAA receptor-mediated presynaptic inhibi-
tion [25,26]. When the stimulation^response relationships
were examined, the femoral nerve-evoked peak amplitude of
tgla/tgla DRP was found to be smaller than that of +/+ DRP
(signi¢cant di¡erences at 800 and 1000 Ws, P6 0.05) (Fig. 4A).
However, the evoked DRP was inhibited to a similar extent
by a GABAA receptor antagonist, bicuculline (Fig. 4B). In the
DRP, there was a slow component (sDRP), which was evoked
by relatively strong stimulation and prolonged by bicuculline
treatment (data not shown). In +/+ mice, this sDRP was
prominent and became larger when the pulse width of stimuli
was increased. In contrast, sDRP tended to be smaller and no
increase with the pulse width was observed in tgla/tgla mice
(signi¢cant di¡erence at 1000 Ws, P6 0.05) (Fig. 4C).
4. Discussion
The principal ¢nding of the present investigation is that
tgla/tgla mice demonstrate altered acute mechanical and ther-
mal nociceptive responses. These results suggest that the P/Q-
type Ca2 channel participates in the modulation of acute
nociceptive transmission. However, these results are in con-
trast with our previous observations using mice lacking
Cav2.2/K1B (N-type channel) [27] or Cav2.3/K1E (R-type chan-
nel) subunit [28]. These knockout mice represent almost no
major de¢cits in acute somatosensory nociceptive tests, sug-
gesting that each type of HVA Ca2 channel participates dif-
ferentially in nociceptive transmission.
We speculated that the altered phenotype of tgla/tgla might
be related to some functional de¢cits of endogenous antino-
ciceptive mechanism in the spinal cord. In particular, we ob-
served the thermal hyperalgesic behavior irrespective of the
slight ataxic nature of this mutant, because there are several
reports suggesting that the P/Q-type channel is preferentially
involved in inhibitory neurotransmission in spinal dorsal horn
in the normal state [4,29,30]. Our electrophysiological studies
showed a reduced ability for producing DRP in tgla/tgla mice
compared with +/+ mice. The presynaptic inhibitory system
including GABAergic interneurons is known to be responsible
for DRP [25,26]. GABAergic and/or excitatory interneurons
both depolarize primary a¡erent terminals leading to the in-
hibition of neurotransmitter release. Thus it is possible that
the reduction of this antinociceptive system is responsible for
the enhanced thermal sensitivity of tgla/tgla mice, although
further studies are necessary to substantiate this possibility.
The results, showing that a relatively greater di¡erence of
peak DRP between +/+ and tgla/tgla mice was evident at a
longer pulse width, might be due to the in£uence of the spill-
over of substances involved in the generation of sDRP, which
also tended to be smaller in tgla/tgla mice. Although the neuro-
transmitters and the mechanism contributing to the genera-
tion of the sDRP remain to be clari¢ed, possible participation
of non-synaptic transmission by several substances such as
glutamate and K has been suggested [25,26].
The other antinociceptive system examined was the opioid
system. In this study we could not observe any di¡erence of
the inhibitory e¡ects of exogenously applied opioid peptides,
suggesting that opioid (W and U) receptor-mediated signal
transduction systems are normal in tgla/tgla spinal cord. How-
ever, further experiments are required to determine whether
expression levels and/or release mechanisms of endogenous
opioid peptides are a¡ected.
It is worth noting that we found no functional contribution
of P/Q-type channels on MSR and sVRP in tgla/tgla spinal
cord in spite of the observation of a small amount of P-type
Ca2 current in cerebellar Purkinje cells from this mutant [15^
17]. The tgla mutation results in the expression of the P/Q-type
channel containing aberrant carboxy-terminal sequences [11].
The carboxy-terminal region has been implicated in several
important functions, including proper channel localization
[31,32]. It is possible that a lower level of P/Q-type current,
which was observed in the cerebellar Purkinje cells, may be
present in spinal neurons expressing P/Q-type channels in tgla/
tgla mice. This P/Q-type channel may not be localized in the
proper site and/or the current may be under the threshold for
eliciting MSR and sVRP.
Another prominent consequence of in vitro electrophysio-
logical experiments was the apparent functional compensation
of the P/Q-type channel defect with the N-type channel in the
tgla/tgla spinal cord. The functional signi¢cance of this com-
pensation should be clari¢ed in future studies. Similar partial
compensation with N-type channel and enhanced reliance on
N-type channel in Cav2.1/K1A-null mutant mice are also ob-
served [13,14].
An immunohistochemical study has shown that the distri-
bution of P/Q-type channels complements rather than coloca-
lizes with N-type channels in the super¢cial dorsal horn [33].
Furthermore, the study also demonstrated the presence of P/
Q-type channels primarily in the nerve terminals in laminae
II^VI, but unlike N-type channels, rarely in substance P-con-
taining neurons. Electrophysiological experiments suggested
that dorsal root ganglion (DRG) neurons express a variety
of VDCCs [34,35]. Each group of DRG neurons classi¢ed
by their sizes contains several types of VDCCs in di¡erent
proportions and non-L/non-N (presumptive P/Q) current is
shown to be relatively expressed in medium and large cells
[34], which might be compatible with the reduced mechanical
sensitivity in tgla/tgla mice, since large and medium DRG neu-
rons constitute myelinated primary sensory neurons (AL- and
AN-¢bers) that contribute to tactile and touch sensations. The
functional relationships between the P/Q-type channel muta-
tion and the reduced mechanical response in tgla/tgla mice
observed at P7^9 in this study requires further experimenta-
tion, because ataxic behavior starts to emerge after P10. Un-
recognized motor and/or neurological de¢cits may a¡ect the
behavior even at P7^9. But the response to thermal stimuli is
more prominent in tgla/tgla than in +/+ mice. It seems unlikely
that the similar withdrawal response only to mechanical stim-
uli is deteriorated. Furthermore tgla/+ mice showed a reduced
response to mechanical stimuli compared to +/+. Even though
further rigorous experiments might be needed to obtain con-
clusive evidence, we suggest here that the P/Q-type channel is
also involved in acute mechanical pain transmission.
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